Kineticos Life Sciences

Kineticos Life Sciences is a growth and venture investor focused on companies striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. We envision a world without Cancer, Rare and Neurodegenerative Diseases, and Antimicrobial Resistance. Kineticos invests in companies focused on significant, unmet medical needs across contract services, manufacturing, equipment, and therapeutic companies. In addition to targeting these disease states and sectors, we look for life science companies utilizing disruptive technologies such as cell and gene therapy, gene editing, and mRNA/RNAi, all technologies dramatically changing how medicine is practiced. For more information on Kineticos and its...

Biopharmaceutical consulting,cro consulting,cmo consulting,diagnostics consulting,lab consulting,venture capital,growth equity,and private equity

Kineticos life sciences operates in the Venture capital and private equity principals industry.

Kineticos life sciences's revenue is 11m - 100m

Kineticos life sciences has 11 - 50 employees.